ASX
Clarity Pharmaceuticals Ltd
CU6:ASX•Healthcare
Sensitive ASX Announcement
Positive topline results from SAR-bisPSMA diagnostic trial
Published: 14/12/22, 09:30am (AEST)•3 pages